Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Oct 15, 2026; 18(10): 121850
Published online Oct 15, 2026. doi: 10.4251/wjgo.121850
Published online Oct 15, 2026. doi: 10.4251/wjgo.121850
Table 2 Survival outcomes based on Fusobacterium nucleatum expression in colorectal cancer
| Outcome | Studies, n | Patients (low vs high), n | HR | 95%CI | P value | RMST low (95%CI) | RMST high (95%CI) | RMST difference | RMST P value |
| Overall survival | 8 | 1091 (682 vs 409) | 0.99 | 0.82–1.20 | 0.93 | 92.5 (87.18–96.9) | 91.4 (85.81–97.2) | 1.0 | 0.462 |
| Disease-free survival | 3 | 1053 (572 vs 481) | 0.45 | 0.37–0.56 | < 0.001 | 102.4 (99.0–105.9) | 80.5 (75.8–85.3) | 21.8 | 0.002 |
| Cancer-specific survival | 4 | 630 (185 vs 445) | 0.34 | 0.26–0.44 | < 0.001 | 83.4 (77.0–90.0) | 45.0 (40.4–49.5) | 38.4 | 0.002 |
- Citation: Liu YX, Chen ZH, Dou GJ, Lu JJ, Zhou Y. Prognostic significance of Fusobacterium nucleatum in colorectal cancer using reconstructed survival data. World J Gastrointest Oncol 2026; 18(10): 121850
- URL: https://www.wjgnet.com/1948-5204/full/v18/i10/121850.htm
- DOI: https://dx.doi.org/10.4251/wjgo.121850